Found: 2
Select item for more details and to access through your institution.
The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46542-y
- By:
- Publication type:
- Article
A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 2, p. e2146912, doi. 10.1001/jamanetworkopen.2021.46912
- By:
- Publication type:
- Article